The role of n-3 long chain polyunsaturated fatty acids in cardiovascular disease prevention, and interactions with statins
The role of n-3 long chain polyunsaturated fatty acids in cardiovascular disease prevention, and interactions with statins
Decreases in global cardiovascular disease (CVD) mortality and morbidity in recent decades can be partly attributed to cholesterol reduction through statin use. n-3 long chain polyunsaturated fatty acids are recommended by some authorities for primary and secondary CVD prevention, and for triglyceride reduction. The residual risk of CVD that remains after statin therapy may potentially be reduced by n-3 long chain polyunsaturated fatty acids. However, the effects of concomitant use of statins and n-3 long chain polyunsaturated fatty acids are not well understood. Pleiotropic effects of statins and n-3 long chain polyunsaturated fatty acids overlap. For example, cytochrome P450 enzymes that metabolize statins may affect n-3 long chain polyunsaturated fatty acid metabolism and vice versa. Clinical and mechanistic study results show both synergistic and antagonistic effects of statins and n-3 long chain polyunsaturated fatty acids when used in combination
Bird, Julia K.
947c4936-5f2c-4f84-99ea-8873003dcbf7
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Eggersdorfer, Manfred
b69f6f28-accd-4e30-9a98-520933b8c40d
15 June 2018
Bird, Julia K.
947c4936-5f2c-4f84-99ea-8873003dcbf7
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Eggersdorfer, Manfred
b69f6f28-accd-4e30-9a98-520933b8c40d
Bird, Julia K., Calder, Philip and Eggersdorfer, Manfred
(2018)
The role of n-3 long chain polyunsaturated fatty acids in cardiovascular disease prevention, and interactions with statins.
Nutrients, 10 (6), [775].
(doi:10.3390/nu10060775).
Abstract
Decreases in global cardiovascular disease (CVD) mortality and morbidity in recent decades can be partly attributed to cholesterol reduction through statin use. n-3 long chain polyunsaturated fatty acids are recommended by some authorities for primary and secondary CVD prevention, and for triglyceride reduction. The residual risk of CVD that remains after statin therapy may potentially be reduced by n-3 long chain polyunsaturated fatty acids. However, the effects of concomitant use of statins and n-3 long chain polyunsaturated fatty acids are not well understood. Pleiotropic effects of statins and n-3 long chain polyunsaturated fatty acids overlap. For example, cytochrome P450 enzymes that metabolize statins may affect n-3 long chain polyunsaturated fatty acid metabolism and vice versa. Clinical and mechanistic study results show both synergistic and antagonistic effects of statins and n-3 long chain polyunsaturated fatty acids when used in combination
Text
nutrients-314642_Accepted Version
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
nutrients-10-00775
- Version of Record
More information
Accepted/In Press date: 13 June 2018
e-pub ahead of print date: 15 June 2018
Published date: 15 June 2018
Identifiers
Local EPrints ID: 421513
URI: http://eprints.soton.ac.uk/id/eprint/421513
PURE UUID: 93776538-a749-49aa-8f2f-749d2ced3086
Catalogue record
Date deposited: 14 Jun 2018 16:30
Last modified: 16 Mar 2024 02:51
Export record
Altmetrics
Contributors
Author:
Julia K. Bird
Author:
Manfred Eggersdorfer
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
